These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 22074738)

  • 21. Functional domains of the BACE1 and BACE2 promoters and mechanisms of transcriptional suppression of the BACE2 promoter in normal neuronal cells.
    Lahiri DK; Maloney B; Ge YW
    J Mol Neurosci; 2006; 29(1):65-80. PubMed ID: 16757811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A series of molecular modeling techniques to reveal selective mechanisms of inhibitors to β-Site amyloid precursor protein cleaving enzyme 1 (BACE1) and β-site amyloid precursor protein cleaving enzyme 2 (BACE2).
    Li S; Zhao H; Li J; Hao J; Yu H
    J Biomol Struct Dyn; 2021 May; 39(8):2824-2837. PubMed ID: 32276567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BACE2 plays a role in the insulin receptor trafficking in pancreatic ß-cells.
    Casas S; Casini P; Piquer S; Altirriba J; Soty M; Cadavez L; Gomis R; Novials A
    Am J Physiol Endocrinol Metab; 2010 Dec; 299(6):E1087-95. PubMed ID: 20943756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a BACE1 Binding Peptide Candidate for the Prevention of Amyloid Beta in Alzheimer's Disease.
    Read J; Suphioglu C
    Cell Physiol Biochem; 2019; 53(2):413-428. PubMed ID: 31415717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells.
    Rochin L; Hurbain I; Serneels L; Fort C; Watt B; Leblanc P; Marks MS; De Strooper B; Raposo G; van Niel G
    Proc Natl Acad Sci U S A; 2013 Jun; 110(26):10658-63. PubMed ID: 23754390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prion protein is decreased in Alzheimer's brain and inversely correlates with BACE1 activity, amyloid-β levels and Braak stage.
    Whitehouse IJ; Miners JS; Glennon EB; Kehoe PG; Love S; Kellett KA; Hooper NM
    PLoS One; 2013; 8(4):e59554. PubMed ID: 23577068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.
    Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W
    Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of BACE2 as an avid ß-amyloid-degrading protease.
    Abdul-Hay SO; Sahara T; McBride M; Kang D; Leissring MA
    Mol Neurodegener; 2012 Sep; 7():46. PubMed ID: 22986058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigational BACE inhibitors for the treatment of Alzheimer's disease.
    Imbimbo BP; Watling M
    Expert Opin Investig Drugs; 2019 Nov; 28(11):967-975. PubMed ID: 31661331
    [No Abstract]   [Full Text] [Related]  

  • 31. Altered amyloid-beta metabolism and deposition in genomic-based beta-secretase transgenic mice.
    Chiocco MJ; Kulnane LS; Younkin L; Younkin S; Evin G; Lamb BT
    J Biol Chem; 2004 Dec; 279(50):52535-42. PubMed ID: 15452128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BACE1 mRNA expression in Alzheimer's disease postmortem brain tissue.
    Coulson DT; Beyer N; Quinn JG; Brockbank S; Hellemans J; Irvine GB; Ravid R; Johnston JA
    J Alzheimers Dis; 2010; 22(4):1111-22. PubMed ID: 20930286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BACE2, a beta -secretase homolog, cleaves at the beta site and within the amyloid-beta region of the amyloid-beta precursor protein.
    Farzan M; Schnitzler CE; Vasilieva N; Leung D; Choe H
    Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9712-7. PubMed ID: 10931940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. β-Secretase activity in rat astrocytes: translational block of BACE1 and modulation of BACE2 expression.
    Bettegazzi B; Mihailovich M; Di Cesare A; Consonni A; Macco R; Pelizzoni I; Codazzi F; Grohovaz F; Zacchetti D
    Eur J Neurosci; 2011 Jan; 33(2):236-43. PubMed ID: 21073551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BACE1 Cleavage Site Selection Critical for Amyloidogenesis and Alzheimer's Pathogenesis.
    Zhang S; Wang Z; Cai F; Zhang M; Wu Y; Zhang J; Song W
    J Neurosci; 2017 Jul; 37(29):6915-6925. PubMed ID: 28626014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The β-Secretase Enzyme BACE1: A Biochemical Enigma for Alzheimer's Disease.
    Shah H; Patel A; Parikh V; Nagani A; Bhimani B; Shah U; Bambharoliya T
    CNS Neurol Disord Drug Targets; 2020; 19(3):184-194. PubMed ID: 32452328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenotypic and biochemical analyses of BACE1- and BACE2-deficient mice.
    Dominguez D; Tournoy J; Hartmann D; Huth T; Cryns K; Deforce S; Serneels L; Camacho IE; Marjaux E; Craessaerts K; Roebroek AJ; Schwake M; D'Hooge R; Bach P; Kalinke U; Moechars D; Alzheimer C; Reiss K; Saftig P; De Strooper B
    J Biol Chem; 2005 Sep; 280(35):30797-806. PubMed ID: 15987683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of AM-6494: A Potent and Orally Efficacious β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor with in Vivo Selectivity over BACE2.
    Pettus LH; Bourbeau MP; Bradley J; Bartberger MD; Chen K; Hickman D; Johnson M; Liu Q; Manning JR; Nanez A; Siegmund AC; Wen PH; Whittington DA; Allen JR; Wood S
    J Med Chem; 2020 Mar; 63(5):2263-2281. PubMed ID: 31589043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
    Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
    Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Common BACE2 Polymorphisms are Associated with Altered Risk for Alzheimer's Disease and CSF Amyloid Biomarkers in APOE ε4 Non-Carriers.
    Huentelman M; De Both M; Jepsen W; Piras IS; Talboom JS; Willeman M; Reiman EM; Hardy J; Myers AJ
    Sci Rep; 2019 Jul; 9(1):9640. PubMed ID: 31270419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.